Why Amgen Is Buying Onyx for $10.4B

Aug. 26 (Bloomberg) -- Amgen agreed to buy Onyx Pharmaceuticals in a $10.4 billion transaction that gives Amgen access to a rapidly expanding cancer-drug market with a new product that offers sure revenue. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)
Nepal Tycoon Chaudhary 'Mobilizing All Resources' to Help
21:02 - Binod Chaudhary, whose Chaudhary Group runs investments from instant noodles to finance in Nepal, talks about the country's worst earthquake in decades and the outlook for rescue efforts. He speaks from Kathmandu with Rishaad Salamat on Bloomberg Television's "Trending Business." (Source: Bloomberg)
  • Indonesian Stocks Slide After Monday’s Plunge
  • Evolution Mining: Iron-Ore Price Drop Positive for Gold
  • Finding Survivors in Nepal With Google's ‘Person Finder’